EDAG regulates the proliferation and differentiation of hematopoietic cells and resists cell apoptosis through the activation of nuclear factor-κB

Cell Death and Differentiation

Volumn 11, Issue 12, 2004, Pages 1299-1308

  Li, C Y ^a   Zhan, Y Q ^a   Xu, C W ^a   Xu, W X ^a   Wang, S Y ^a,b   Lv, J ^a   Zhou, Y ^a,b   Yue, P B ^a   Chen, B ^a,b   Yang, Xiao Ming ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Differentiation; EDAG; NF B; Proliferation

Indexed keywords

CD11B ANTIGEN; ERYTHROID DIFFERENTIATION ASSOCIATED PROTEIN; HEMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; MYC PROTEIN; MYRISTIC ACID DERIVATIVE; PROTEIN BCL 2; PROTEIN BCL XL; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA BINDING; DOWN REGULATION; ERYTHROID CELL; GENE OVEREXPRESSION; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; TRANSCRIPTION REGULATION;

ANTIGENS, CD11B; APOPTOSIS; BCL-X PROTEIN; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DNA-BINDING PROTEINS; ERYTHROID PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; NF-KAPPA B; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 20844437073     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401490     Document Type: Article

References (34)

1. Yang LV, Nicholson RH, Kaplan J, Galy A and Li L (2001) Hemogen is a novel nuclear factor specifically expressed in mouse hematopoietic development and its human homologue EDAG maps to chromosome 9q22, a region containing breakpoints of hematological neoplasms. Mech. Dev. 104: 105-111
2. Wurtz T, Kruger A, Christersson C and Lundmark C (2001) A new protein expressed in bone marrow cells and osteoblasts with implication in osteoblast recruitment. Exp. Cell Res. 263: 236-242
3. Xu WX, Wei HD, Wang SY and Yang XM (2001) Isolation of specific expression gene in human fetal liver by representational difference analysis. Chin. J. Appl. Physiol. 17: 192-194
4. Lu J, Xu WX, Wang SY, Zhan YQ, Jiang Y, Cai WM and Yang XM (2001) Isolation and characterization of EDAG-1, a novel gene related to regulation in hematopoietic system. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 33: 641-646
5. Lu J, Xu WX, Wang SY, Jiang Y, Li CY, Cai WM and Yang XM (2002) Overexpression of EDAG in NIH3T3 cells leads to malignant transformation [article in Chinese). Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao, (Shanghai) 34: 95-98
6. Johansson B, Fioretos T and Mitelman F (2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol. 107: 76-94
7. Kruger A, Ellerstrom C, Lundmark C, Christersson C and Wurtz T (2002) RP59, a marker for osteoblast recruitment, is also detected in primitive mesenchymal cells, erythroid cells, and megakaryocytes. Dev. Dyn. 223: 414-418
8. Pae HO, Seo WG, Kim NY, Oh GS, Kim GE, Kim YH, Kwak HJ, Yun YG, Jun CD and Chung HT (2001) Induction of granulocytic differentiation in acute promyelocytic leukemia cells (HL-60) by water-soluble chitosan oligomer. Leuk. Res. 25: 339-346
9. Keller SA, Schattner EJ and Cesarman E (2000) Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96: 2537-2542
10. Bourgeade MF, Defachelles AS and Cayre YE (1998) Myc is essential for transformation by TEL/platelet-derived growth factor receptor beta (PDGFRbeta). Blood 91: 3333-3339
11. Mahmud N, Katayama N, Nishii K, Sugawara T, Komada. Y, Mitani H, Araki H, Ohishi K, Watanabe M, Masuya M, Nishikawa M, Minami N, Ohashi H and Shiku H (1999) Possible involvement of bcl-2 in regulation of cell-cycle progression of haemopoietic cells by transforming growth factor-beta1. Br. J. Haematol. 105: 470-477
12. Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C, Mollat P, Gisselbrecht S and Gouilleux F (1999) IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene 18: 4191-4199
13. Hunter T (1997) Oncoprotein networks. Cell 88: 333-346
14. Herschman HR (1991) Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60: 281-319
15. Adams JM and Cory S (1992) Oncogene co-operation in leukaemogenesis. Cancer Surv. 15: 119-141
16. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K and Oberg F (2002) Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 99: 2199-2206
17. McArthur GA, Foley KP, Fero ML, Walkley CR, Deans AJ, Roberts JM and Eisenman RN (2002) MAD1 and p27(KIP1) cooperate to promote terminal differentiation of granulocytes and to inhibit Myc expression and cyclin E-CDK2 activity. Mol. Cell Biol. 22: 3014-3023
18. Delgado MD, Lerga A, Canelles M, Gomez-Casares MT and Leon J (1995) Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene 10: 1659-1665
19. Collins JF, Herman P, Schuch C and Bagby Jr. GC (1992) c-myc antisense oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells. J. Clin. Invest. 89: 1523-1527
20. Canelles M, Delgado MD, Hyland KM, Lerga A, Richard C, Dang CV and Leon J (1997) Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells. Oncogene 14: 1315-1327
21. Besancon F, Atfi A, Gespach C, Cayre YE and Bourgeade MF (1998) Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein. Proc. Natl. Acad. Sci. USA. 95: 8081-8086
22. Bush JA and Li G (2003) The role of Bcl-2 family members in the progression of cutaneous melanoma. Clin. Exp. Metast. 20: 531-539
23. Spiekermann K, Pau M, Schwab R, Schmieja K, Franzrahe S and Hiddemann W (2002) Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells. Exp. Hematol. 30: 262-271
24. Ho JM, Nguyen MH, Dierov JK, Badger KM, Beattie BK, Tartaro P, Haq R, Zanke BW, Carroll MP and Barber DL (2002) TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways. Blood 100: 1438-1448
25. Chevray PM and Nathans D (1992) Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun. Proc. Natl. Acad. Sci. USA 89: 5789-5793
26. McWhirter JR, Galasso DL and Wang JY (1993) A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol. Cell Biol. 13: 7587-7595
27. Pfitzner E, Becker P, Rolke A and Schule R (1995) Functional antagonism between the retinoic acid receptor and the viral transactivator BZLF1 is mediated by protein-protein interactions. Proc. Natl. Acad. Sci. USA 92: 12265-12269
28. Harada H, Harada Y, O'Brien DP, Rice DS, Naeve CW and Downing JR (1999) HERF1, a novel hematopoiesis-specific RING finger protein, is required for terminal differentiation of erythroid cells. Mol. Cell Biol. 19: 3808-3815
29. Haslinger A and Karin M (1985) Upstream promoter element of the human metallothionein-IIA gene can act like an enhancer element. Proc. Natl. Acad. Sci. USA 82: 8572-8576
30. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM and Stober W (eds) (1991) Current Protocols in Immunology Vol. 1 New York: John Wiley and Sons pp 7.1.1-7.1.3
31. Baliga BS, Mankad M, Shah AK and Mankad VN (1993) Mechanism of differentiation of human erythroleukaemic cell line K562 by hemin. Cell Prolif. 26: 519-529
32. Seo J, Kim M and Kim J (2000) Identification of novel genes differentially expressed in PMA-induced HL-60 cells using cDNA microarrays. Mol. Cells 10: 733-739
33. Athanasiou M, Mavrothalassitis G, Sun-Hoffman and Blair DG (2000) Fli-1 is a suppressor of erythroid differentiation in human hematopoietic. Leukemia 14: 439-445
34. Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C, Mollat P, Gisselbrecht S and Gouilleux F (1999) IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. OnGogene 18: 4191-4199